View Older Stories

Apr 28, 2025 06:40AM BMO Capital Reiterates Outperform Rating on Abbvie (ABBV)

Apr 9, 2025 09:19AM Pharma stocks slide after Trump signals tariffs on sector

Mar 4, 2025 10:16AM BMO Capital Reiterates Outperform Rating on Abbvie (ABBV) as They Enter Obesity

Mar 4, 2025 10:16AM BMO Capital Reiterates Outperform Rating on Abbvie (ABBV) as They Enter Obesity

Feb 3, 2025 08:28AM Abbvie (ABBV) PT Raised to $215 at BMO Capital as 'Guidance Raise Gives More Confidence'

Jan 16, 2025 11:50AM BMO Capital Reiterates Outperform Rating on Abbvie (ABBV) as I&I Portfolio Sees New Avenues for Growth in 2025

Nov 12, 2024 09:08AM Abbvie (ABBV) PT Lowered to $208 at BMO Capital

Oct 31, 2024 08:14AM Abbvie (ABBV) PT Raised to $228 at BMO Capital

Sep 26, 2024 12:13PM BMO Capital Reiterates Outperform Rating on Abbvie (ABBV)

Jul 25, 2024 07:39AM AbbVie lifts 2024 profit forecast, shares hit record high

Jul 19, 2024 08:55AM Abbvie (ABBV) PT Raised to $214 at BMO Capital

Apr 29, 2024 09:39AM Abbvie (ABBV) PT Lowered to $180 at BMO Capital

Apr 26, 2024 07:44AM Drugmaker AbbVie expects Humira volume erosion to worsen

Nov 30, 2023 09:27AM Immunogen (IMGN) shares surge on news of takeover by AbbVie (ABBV)

Nov 30, 2023 07:45AM AbbVie seeks lift from 'guided missile' cancer drug with $10 billion ImmunoGen deal

Apr 27, 2023 07:48AM AbbVie posts weak sales of newer drugs as Humira faces fresh competition, shares fall

Feb 23, 2022 07:13AM Abbvie (ABBV) PT Raised to $161 at BMO Capital Following Migraine Deep Dive

Feb 3, 2022 07:19AM Abbvie (ABBV) PT Raised to $154 at BMO Capital

Jan 12, 2022 06:45AM Abbvie (ABBV) PT Raised to $153 at BMO Capital Following Bullish Update

Nov 1, 2021 07:28AM Abbvie (ABBV) PT Raised to $134 at BMO Capital

May 3, 2021 07:31AM Abbvie (ABBV) PT Raised to $129 at BMO Capital

Nov 18, 2020 06:54AM BMO Capital Starts Abbvie (ABBV) at Outperform; Well-Positioned to Manage Humira's LOE

Apr 28, 2019 11:47PM UPDATE: BMO Capital Upgrades Abbvie (ABBV) to Market Perform

Nov 5, 2018 08:47AM Abbvie (ABBV) PT Lowered to $71 at BMO Capital

Nov 2, 2018 07:52AM AbbVie sees hit to Humira sales from European competition

Sep 19, 2018 12:42PM Abbvie (ABBV) CA Suit 'Incrementally Negative' - BMO

Jun 1, 2018 01:21PM Olumiant 2mg FDA Approval is Incrementally Negative for AbbVie (ABBV) - BMO

May 23, 2018 07:54AM Abbvie (ABBV) PT Lowered to $78 at BMO Capital

Apr 27, 2018 09:28AM Abbvie (ABBV) PT Raised to $81 at BMO Capital

Apr 19, 2018 09:41AM Bari Adcom Negative for Eli Lilly (LLY) and AbbVie (ABBV), Positive for Pfizer (PFE) - BMO

Mar 22, 2018 10:41AM AbbVie (ABBV) Has Downside as Underappreciated Risks are Materializing - BMO Capital

Jan 30, 2018 03:01PM AbbVie (ABBV), Eli Lilly (LLY) More Vulnerable Than Other Drug Cos. on Amazon Entry - BMO

Jan 29, 2018 07:34AM BMO Capital Downgrades Abbvie (ABBV) to Underperform; 'Risk/Reward Skewed to the Downside'

May 17, 2017 06:18AM AbbVie (ABBV): The Upside To IPR Loss - BMO

May 2, 2017 09:00AM Abbvie (ABBV) PT Raised to $66 at BMO Capital; 'Should Finish 2017 at Top-End of Guidance'

Apr 20, 2017 06:37AM AbbVie (ABBV): Pipeline Confidence Weakening - BMO

Apr 18, 2017 06:43AM AbbVie (ABBV): Still Concerned About Long Term - BMO

Nov 9, 2016 12:03PM Complete Donald Trump Stock Impact Guide

Nov 9, 2016 07:54AM Major Pharma Got a Major Win Last Night - BMO

Nov 7, 2016 01:40PM Abbvie (ABBV) PTAB Decision Incrementally Positive, But Does Not Change Cautious Thesis - BMO

Oct 18, 2016 07:08AM Inflectra's U.S. Launch Incrementally Positive for Pfizer (PFE), Negative for AbbVie (ABBV) - BMO

Jul 29, 2016 12:07PM Streetinsider.com's Hot Lunchtime Reads 7/29: (WDC) (EPIQ) (ABBV) (ININ)

Jul 29, 2016 11:54AM BMO Capital Keeps AbbVie (ABBV) at 'Market Perform'; Says Humira Solid in Q2, but Questions Remain

Jun 10, 2016 08:37AM UPDATE: BMO Capital Downgrades Abbvie (ABBV) to Market Perform

May 17, 2016 12:24PM BMO Capital Weighs in on Abbvie (ABBV) Amid IPR Decision

Jan 15, 2016 06:55AM BMO Capital Positive on Abbvie (ABBV) Humira Win Versus Amgen (AMGN)

Apr 23, 2015 12:15PM Streetinsider.com's Hot Lunchtime Reads 4/23: (GILD) (FB) (ABBV) (HLF)

Apr 23, 2015 11:47AM Abbvie (ABBV) Weakness Related to Hep-C Data from Gilead (GILD), BMO Capital Says

Apr 20, 2015 03:25PM Pharmacyclics (PCYC) Imbruvica CLL Update a Positive for Suitor Abbvie (ABBV) - BMO Capital

Apr 13, 2015 10:30AM Notable Analyst Rating Changes 4/13: (NFLX) (ABBV) (UNH) Upgraded; (ANR) (PDS) (OMC) Downgraded

View Older Stories